Canadian drug price regulator may be flexible on rare diseases

>

Sharing is caring!

Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in setting price caps for drugs that treat rare diseases, the agency’s executive director told Reuters, as some advocates warned the country’s pricing reforms would hurt patients.

script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js">


Read More

Sharing is caring!

Second ad

This site uses Akismet to reduce spam. Learn how your comment data is processed.